122 related articles for article (PubMed ID: 15194230)
1. Genetic regulation of mouse glycosylphosphatidylinositol-phospholipase D.
Flores-Borja F; Kieszkievicz J; Church V; Francis-West PH; Schofield J; Rademacher TW; Lund T
Biochimie; 2004; 86(4-5):275-82. PubMed ID: 15194230
[TBL] [Abstract][Full Text] [Related]
2. Glucose and insulin regulate glycosylphosphatidylinositol-specific phospholipase D expression in islet beta cells.
Bowen RF; Raikwar NS; Olson LK; Deeg MA
Metabolism; 2001 Dec; 50(12):1489-92. PubMed ID: 11735099
[TBL] [Abstract][Full Text] [Related]
3. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.
Raikwar NS; Cho WK; Bowen RF; Deeg MA
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662
[TBL] [Abstract][Full Text] [Related]
4. Anti-mouse GPI-PLD antisera highlight structural differences between murine and bovine GPI-PLDs.
Gregory P; Ziemiecki A; Zürcher G; Brodbeck U; Bütikofer P
Biol Chem; 2003 Dec; 384(12):1575-82. PubMed ID: 14719799
[TBL] [Abstract][Full Text] [Related]
5. [Effect of overexpression of glycosylphosphatidylinositol-specific phospholipase D on biological character of hepatocellular carcinoma cell line HepG2].
He WJ; Tang JH; Tan CC; Duan Q; Wang KJ; Zuo KQ; Yuan XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):103-9. PubMed ID: 18326903
[TBL] [Abstract][Full Text] [Related]
6. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary study of the gene structure of human glycosylphosphatidylinositol specific phospholipase D].
Tang JH; Gu SL; Zhang XJ
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):95-7. PubMed ID: 12536633
[TBL] [Abstract][Full Text] [Related]
8. GPI-specific phospholipase D (GPI-PLD) is expressed during mouse development and is localized to the extracellular matrix of the developing mouse skeleton.
Gregory P; Kraemer E; Zürcher G; Gentinetta R; Rohrbach V; Brodbeck U; Andres AC; Ziemiecki A; Bütikofer P
Bone; 2005 Aug; 37(2):139-47. PubMed ID: 15946906
[TBL] [Abstract][Full Text] [Related]
9. A distant evolutionary relationship between GPI-specific phospholipase D and bacterial phosphatidylcholine-preferring phospholipase C.
Rigden DJ
FEBS Lett; 2004 Jul; 569(1-3):229-34. PubMed ID: 15225639
[TBL] [Abstract][Full Text] [Related]
10. [Competitive RT-PCR assay for quantification of GPI-PLD gene expression].
Zhang XJ; Lu CP; Tang JH
Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):322-6. PubMed ID: 14653107
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes.
Deeg MA; Bowen RF; Williams MD; Olson LK; Kirk EA; LeBoeuf RC
Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E147-54. PubMed ID: 11404232
[TBL] [Abstract][Full Text] [Related]
12. Important roles of glycosylphosphatidylinositol (GPI)-specific phospholipase D and some GPI-anchored proteins in the pathogenesis of hepatocellular carcinoma.
Tang JH; He WJ; Huang H; Tan CC; Duan Q; Wang KJ; Yuan XY; Zhu XJ
Clin Biochem; 2009 Mar; 42(4-5):400-7. PubMed ID: 19135435
[TBL] [Abstract][Full Text] [Related]
13. Midportion antibodies stimulate glycosylphosphatidylinositol-specific phospholipase D activity.
Deeg MA; Bowen RF
Arch Biochem Biophys; 1999 Oct; 370(2):278-84. PubMed ID: 10510287
[TBL] [Abstract][Full Text] [Related]
14. Mouse glycosylphosphatidylinositol-specific phospholipase D (Gpld1) characterization.
LeBoeuf RC; Caldwell M; Guo Y; Metz C; Davitz MA; Olson LK; Deeg MA
Mamm Genome; 1998 Sep; 9(9):710-4. PubMed ID: 9716655
[TBL] [Abstract][Full Text] [Related]
15. Cleavage of carcinoembryonic antigen induces metastatic potential in colorectal carcinoma.
Yamamoto Y; Hirakawa E; Mori S; Hamada Y; Kawaguchi N; Matsuura N
Biochem Biophys Res Commun; 2005 Jul; 333(1):223-9. PubMed ID: 15958210
[TBL] [Abstract][Full Text] [Related]
16. Studies of the role of the integrin EF-hand, Ca2+-binding sites in glycosylphosphatidylinositol-specific phospholipase D: reduced expression following mutagenesis of residues predicted to bind Ca2+.
Li JY; Low MG
Arch Biochem Biophys; 1999 Jan; 361(1):142-8. PubMed ID: 9882439
[TBL] [Abstract][Full Text] [Related]
17. [GPI-PLD gene exon14 polymorphisms of leucocyte in peripheral blood from healthy persons and leukemia patients].
Yang ZY; Huang H; Tang JH; Yu H; Wang YD; Xiang XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):28-31. PubMed ID: 16562670
[TBL] [Abstract][Full Text] [Related]
18. Glycosylphosphatidylinositol-specific phospholipase D immunoreactivity is present in islet amyloid in type 2 diabetes.
Larson DM; Kennedy MA; Bowen RF; Verchere CB; Deeg MA
J Pathol; 2004 Aug; 203(4):961-7. PubMed ID: 15259000
[TBL] [Abstract][Full Text] [Related]
19. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.
Masuda S; Fujishima Y; Maeda N; Tsugawa-Shimizu Y; Nakamura Y; Tanaka Y; Obata Y; Fukuda S; Nagao H; Kita S; Nishizawa H; Shimomura I
Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E239-E250. PubMed ID: 30457913
[TBL] [Abstract][Full Text] [Related]
20. Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.
Chalasani N; Vuppalanchi R; Raikwar NS; Deeg MA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2279-85. PubMed ID: 16595594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]